Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of spartalizumab in cancer patients in Japan
jRCT2080223514Phase 2Completed
- Start
- Apr 2017
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of spartalizumab in cancer. Started Apr 2017; status: completed.
02
Drugs
spartalizumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080223514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223514.